Shareholder Votes

Climb Global Solutions, Inc. shareholders approved Approval of the Amended and Restated Climb Global Solutions, Inc. 2021 Omnibus Incentive Plan at the 2026-06-02 meeting.

“Proposal 3: Approval of the Amended and Restated Climb Global Solutions, Inc. 2021 Omnibus Incentive Plan — The final number of votes cast for, against or abstaining from voting and broker non-votes were as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 11,184,814 1,007,042 60,688 2,887,125”

Climb Global Solutions, Inc. shareholders approved Advisory Resolution to Approve Compensation of the Company's Named Executive Officers at the 2026-06-02 meeting.

“Proposal 2: Advisory Resolution to Approve Compensation of the Company ' s Named Executive Officers — The final number of votes cast for, against or abstaining from voting and broker non-votes were as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 11,081,655 1,109,991 60,898 2,887,125”

Climb Global Solutions, Inc. shareholders approved Election of Directors at the 2026-06-02 meeting.

“Proposal 1: Election of Directors — The final number of votes for, withheld and broker-non-votes were as follows: Nominee Votes For Votes Withheld Broker Non- Votes John McCarthy 10,146,437 2,106,107 2,887,125 Andy Bryant 11,139,727 1,112,817 2,887,125 Dale Foster 11,975,398 277,146 2,887,125 Paul Giovacchini 11,336,652 915,892 2,887,125”

Upland Software, Inc. shareholders approved Adjournment Proposal (to permit further solicitation if needed) at the 2026-06-03 meeting.

“The stockholders approved the Adjournment Proposal.”

Upland Software, Inc. shareholders approved Amendment to 2024 Omnibus Incentive Plan to increase reserved shares from 3,200,000 to 5,200,000 at the 2026-06-03 meeting.

“The stockholders approved the Equity Plan Increase Proposal.”

Upland Software, Inc. shareholders approved Reverse Split Proposal (range 1:5 to 1:30) at the 2026-06-03 meeting.

“The stockholders approved the Reverse Split Proposal .”

Upland Software, Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-03 meeting.

“The stockholders approved, on an advisory basis, the compensation of the Company's named executive officers.”

Upland Software, Inc. shareholders approved Ratification of KPMG LLP as independent registered public accounting firm at the 2026-06-03 meeting.

“The stockholders ratified the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Upland Software, Inc. shareholders approved Election of one Class III director at the 2026-06-03 meeting.

“The stockholders elected one Class III director to serve on the Company's board of directors until the Company's 2029 annual meeting of stockholders, or until a successor is duly elected and qualified.”

Coronado Global Resources Inc. shareholders approved Approval of the Issuance of up to 90,000,000 Securities Under the 2018 Equity Incentive Plan Pursuant to ASX Listing Rule 7.2 (Exception 13) and For All Other Purposes at the 2026-06-03 meeting.

“Proposal 6 - Approval of the Issuance of up to 90,000,000 Securities Under the 2018 Equity Incentive Plan Pursuant to ASX Listing Rule 7.2 (Exception 13) and For All Other Purposes. The Common Stockholders voted upon and approved the issuance of up to 90,000,000 Securities under the 2018 Equity Incentive Plan pursuant to ASX Listing Rule 7.2 (Exception 13) and for all other purposes.”

Coronado Global Resources Inc. shareholders approved Ratification of the Appointment of Ernst & Young as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026 at the 2026-06-03 meeting.

“Proposal 5 - Ratification of the Appointment of Ernst & Young as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026 . The Common Stockholders voted upon and approved the ratification of the appointment of Ernst & Young to serve as the Company’s independent registered accountants for the fiscal year ending December 31, 2026.”

Coronado Global Resources Inc. shareholders approved Advisory Vote to Approve the Frequency of Stockholder Votes on Named Executive Officer Compensation at the 2026-06-03 meeting.

“Proposal 4 - Advisory Vote to Approve the Frequency of Stockholder Votes on Named Executive Officer Compensation . The Common Stockholders voted upon and approved “Every Three Years,” by nonbinding, advisory vote, for the frequency of future advisory votes on the compensation of our named executive officers.”

Coronado Global Resources Inc. shareholders approved Advisory Vote to Approve Our Named Executive Officers’ Compensation at the 2026-06-03 meeting.

“Proposal 3 - Advisory Vote to Approve Our Named Executive Officers’ Compensation . The Common Stockholders voted upon and approved, by nonbinding, advisory vote, the compensation of the Company’s named executive officers, as described in the Proxy Statement.”

Coronado Global Resources Inc. shareholders approved Election of Director Nominees at the 2026-06-03 meeting.

“Proposals 1 and 2 - Election of Director Nominees . The Company’s stockholders elected each of the following six director nominees to serve until the Company’s 2027 annual general meeting of stockholders or until a successor is duly elected and qualified.”

ARROW FINANCIAL CORP shareholders approved Ratification of the selection of Crowe LLP as independent auditor for fiscal year ending December 31, 2026 at the 2026-06-03 meeting.

“The ratification of the selection of the independent registered public accounting firm, Crowe LLP, as the Company's independent auditor for the fiscal year ending December 31, 2026.”

ARROW FINANCIAL CORP shareholders approved Advisory approval of the Company's 2025 executive compensation at the 2026-06-03 meeting.

“The approval, on an advisory basis, of the Company’s 2025 executive compensation.”

ARROW FINANCIAL CORP shareholders approved Election of four Class A directors with terms expiring in 2029 at the 2026-06-03 meeting.

“The election of four (4) directors to Class A, for a term of three (3) years and/or until their successors shall have been elected and qualified.”

Bioventus Inc. shareholders approved Ratification of Grant Thornton LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-03 meeting.

“The stockholders also ratified the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The vote for such ratification was 75,228,481 Shares for, 5,021 Shares against, 45,672 Shares abstaining, and no broker non-votes.”

Bioventus Inc. shareholders approved Election of Directors at the 2026-06-03 meeting.

“The following proposals were voted upon at the 2026 Annual Meeting and the final voting results with respect to each such proposal are set forth below. At the 2026 Annual Meeting, the stockholders elected the following directors to serve on the Company’s Board of Directors until the 2027 annual meeting of stockholders and until each such director’s respective successor is elected and qualified, or until each such director’s death, resignation or removal, based on the following votes: Nominee For Withheld Broker Non-Votes William A. Hawkins 67,405,961 1,128,994 6,744,219 John A. Bartholdson 68,365,980 168,975 6,744,219 Patrick J. Beyer 68,062,114 472,841 6,744,219 Robert E. Claypoole 68,360,467 174,488 6,744,219 Philip G. Cowdy 67,748,512 786,443 6,744,219 Ajay Dhankhar 68,459,149 75,806 6,744,219 Mary Kay Ladone 67,160,936 1,374,019 6,744,219 Michelle McMurry-Heath 68,073,685 461,270 6,744,219 Guido J. Neels 68,049,659 485,296 6,744,219 Guy P. Nohra 67,767,651 767,304 6,744,219 Susan M”

Loar Holdings Inc. shareholders approved To approve, on a non-binding advisory basis, the frequency of future stockholder advisory votes on the compensation of our named executive officers every 1, 2 or 3 years at the 2026-06-02 meeting.

“Proposal 4 - to approve, on a non-binding advisory basis, the frequency of future stockholder advisory votes on the compensation of our named executive officers every 1, 2 or 3 years : 1 Year 2 Years 3 Years Abstain Broker Non-Votes 71,950,589 42,262 125,158 2,067 4,062,159”

Loar Holdings Inc. shareholders approved To approve, on a non-binding advisory basis, the compensation of our named executive officers at the 2026-06-02 meeting.

“Proposal 3 - to approve, on a non-binding advisory basis, the compensation of our named executive officers : For Against Abstain Broker Non-Votes 68,741,460 3,375,301 3,315 4,062,159”

Loar Holdings Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-02 meeting.

“Proposal 2 - ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 : For Against Abstain Broker Non-Votes 76,125,490 54,974 1,771 0”

Loar Holdings Inc. shareholders approved Election of three director nominees to the Company's Board of Directors at the 2026-06-02 meeting.

“Proposal 1 - election of three director nominees to the Company's Board of Directors : Nominee For Withheld Broker Non-Votes Raja Bobbili 71,125,296 994,780 4,062,159 Alison Bomberg 64,582,644 7,537,432 4,062,159 Margaret (Peg) McGetrick 71,612,205 507,871 4,062,159”

RadNet, Inc. shareholders approved Approve the amendment and restatement of the Company’s Equity Incentive Plan at the 2026-06-02 meeting.

“Proposal 4 The proposal to approve the amendment and restatement of the Company’s Equity Incentive Plan disclosed in the Company’s 2026 definitive proxy statement was approved based on the following votes: For Against Abstentions Broker Non-Votes 63,254,838 1,844,622 33,746 8,119,301”

RadNet, Inc. shareholders approved Non-binding advisory vote to approve the compensation of Named Executive Officers at the 2026-06-02 meeting.

“Proposal 3 The non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers disclosed in the Company’s 2026 definitive proxy statement was approved based on the following votes: For Against Abstentions Broker Non-Votes 61,158,497 3,892,047 82,662 8,119,301”

RadNet, Inc. shareholders approved Ratify the appointment of Ernst & Young LLP as independent registered public accounting firm for year ending December 31, 2026 at the 2026-06-02 meeting.

“Proposal 2 The proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was approved based on the following votes: For Against Abstentions 72,890,772 346,990 14,745”

RadNet, Inc. shareholders approved Election of six directors to hold office until the 2027 Annual Meeting at the 2026-06-02 meeting.

“Proposal 1 The stockholders elected the following six directors to hold office until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified based on the following votes:”

AVITA Medical, Inc. shareholders approved Approval of the Issuance of Equity Securities under ASX Listing Rule 7.1A at the 2026-06-04 meeting.

“10. Approval of the Issuance of Equity Securities (Proposal 15): Stockholders approved as a special resolution, for the purpose of ASX Listing Rule 7.1A (which allows the Company to seek stockholder approval to issue an additional 10% over the annual listing limit of 15% of its issued capital in a consecutive 12-month period) and all other purposes, the issue of Equity Securities (as defined in ASX Listing Rule 19.2) up to such additional 10% of the issued capital (at the time of issuance) of the Company (as calculated in accordance with ASX Listing Rule 7.1A.2). The votes regarding this proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 8,947,195 2,223,106 531,604 3,890,542”

AVITA Medical, Inc. shareholders approved Approval of the Issuance of Warrants to Perceptive Credit Holdings V, LP at the 2026-06-04 meeting.

“9. Approval of the Issuance of Warrants (Proposal 14): Stockholders approved, for the purpose of ASX Listing Rule 7.1 (and all other purposes), the issuance of a warrant or warrants covering up to 650,000 shares of Common Stock, with a term of ten years (the “Warrants”), to Perceptive Credit Holdings V, LP (“Perceptive”), pursuant to the credit agreement between the Company and Perceptive, dated January 13, 2026. The votes regarding this proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 9,322,532 1,769,627 609,746 3,890,542”

AVITA Medical, Inc. shareholders approved Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation at the 2026-06-04 meeting.

“8. Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation (Proposal 13) : Stockholders voted in favor of the non-binding advisory vote to set the frequency of future advisory votes to approve the compensation of the Company’s named executive officers. The votes regarding this proposal were as follows: Votes For 1 Year 2 Years 3 Years Abstentions Broker Non-Votes 9,545,151 924,743 650,252 581,759 3,890,542”

AVITA Medical, Inc. shareholders approved Advisory Vote to Approve Compensation of Named Executive Officers at the 2026-06-04 meeting.

“7. Advisory Vote to Approve Compensation of Named Executive Officers (Proposal 12) : Stockholders voted in favor of the non-binding advisory vote to approve the compensation of the Company’s named executive officers. The votes regarding this proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 8,918,272 2,202,213 581,420 3,890,542”

AVITA Medical, Inc. shareholders approved Issuance of Securities to Joseph Woody (initial grant) at the 2026-06-04 meeting.

“6. Issuance of Securities to Joseph Woody (Proposal 10) : Stockholders approved the initial grant comprised of 40,547 restricted stock units and 29,446 stock options, to Mr. Joseph Woody, in accordance with the terms and conditions set out in the Proxy Statement. The votes regarding this proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 8,863,312 2,395,376 443,217 3,890,542”

AVITA Medical, Inc. shareholders approved Issuance of Securities to Dr. Michael Tarnoff (initial grant) at the 2026-06-04 meeting.

“5. Issuance of Securities to Dr. Michael Tarnoff (Proposal 8) : Stockholders approved the initial grant comprised of 26,250 restricted stock units and 19,063 stock options, to Dr. Michael Tarnoff, in accordance with the terms and conditions set out in the Proxy Statement. The votes regarding this proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 8,791,498 2,433,367 477,040 3,890,542”

AVITA Medical, Inc. shareholders approved Issuance of Securities to Non-Executive Directors (annual grants to each named director) at the 2026-06-04 meeting.

“4. Issuance of Securities to Non-Executive Directors (Proposals 4 - 7, 9 & 11) : Stockholders approved the annual grants comprised of 22,214 restricted stock units and 16,133 stock options, to each of the following non-executive directors, in accordance with the terms and conditions set out in the Proxy Statement. The votes regarding these proposals were as follows: Votes For Votes Against Abstentions Broker Non-Votes Professor Suzanne Crowe 8,869,562 2,411,009 421,334 3,890,542 Jeremy Curnock Cook 8,722,810 2,544,450 434,645 3,890,542 Robert McNamara 8,818,589 2,449,386 433,930 3,890,542 Jan Stern Reed 8,841,764 2,434,253 425,888 3,890,542 Dr. Michael Tarnoff 8,774,530 2,458,787 468,588 3,890,542 Joseph Woody 8,830,204 2,446,817 424,884 3,890,542”

AVITA Medical, Inc. shareholders approved Increase the maximum aggregate annual cash fee pool from which the non-executive Directors may be paid at the 2026-06-04 meeting.

“3. Increase the maximum aggregate annual cash fee pool from which the non-executive Directors of the Company may be paid (Proposal 3): Stockholders approved, for the purposes of ASX Listing Rule 10.17 and section 2.10 of the Company’s Amended and Restated Bylaws (and for all other purposes), an increase to the aggregate annual cash fee pool from which non-executive directors of the Company may be paid for their services from a maximum of US$750,000 per annum to a maximum of US$900,000 per annum. The votes regarding this proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 8,582,602 2,710,656 408,647 3,890,542”

AVITA Medical, Inc. shareholders approved Ratification of the selection of Grant Thornton LLP as the Company’s independent registered public accounting firm at the 2026-06-04 meeting.

“2. Appointment of Independent Auditor (Proposal 2) : The stockholders ratified the selection of Grant Thornton LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The votes regarding this proposal were as follows: Votes For Votes Against Abstentions 14,962,654 255,151 374,642”

AVITA Medical, Inc. shareholders approved Election of Directors at the 2026-06-04 meeting.

“At the Annual Meeting, the Company’s stockholders voted on all the proposals summarized in the Proxy Statement, as set forth below: 1. Election of Directors (Proposal 1) : All seven directors named in the Proxy Statement were elected to serve on the Company’s Board of Directors with the following votes: Name Votes For Votes Withheld Broker Non-Votes Jan Stern Reed 10,902,991 798,914 3,890,542 Professor Suzanne Crowe 10,979,194 722,711 3,890,542 Jeremy Curnock Cook 10,700,424 1,001,481 3,890,542 Robert McNamara 10,962,888 739,017 3,890,542 Dr. Michael Tarnoff 11,011,908 689,997 3,890,542 Joseph Woody 10,977,874 724,031 3,890,542 Cary Vance 11,176,792 525,113 3,890,542”

Denali Therapeutics Inc. shareholders approved Advisory vote to approve executive compensation at the 2026-06-03 meeting.

“Advisory Vote to Approve Executive Compensation The Company’s stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement.”

Denali Therapeutics Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm at the 2026-06-03 meeting.

“The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified based on the following results of voting:”

Denali Therapeutics Inc. shareholders approved Election of three Class III directors at the 2026-06-03 meeting.

“Election of three Class III directors to hold office until the 2029 annual meeting of stockholders. Each of the following nominees was elected to serve as a Class III director, to hold office until the Company’s 2029 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified or his or her earlier resignation or removal.”

Waystar Holding Corp. shareholders approved Advisory vote on frequency of future say-on-pay votes at the 2026-06-01 meeting.

“3. A frequency of "one year" was selected, on a non-binding advisory basis, as the recommended frequency of future advisory votes to approve the compensation of the Company’s named executive officers as set forth below. One Year Two Years Three Years Abstain Broker Non-Votes 176,047,038 4,742 1,285,275 82,193 3,488,788”

Waystar Holding Corp. shareholders approved Ratification of KPMG LLP as independent auditor for fiscal year 2026 at the 2026-06-01 meeting.

“2. The ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved as set forth below. For Against Abstain Broker Non-Votes 180,884,990 7,071 15,975 N/A”

Waystar Holding Corp. shareholders approved Election of four Class II directors at the 2026-06-01 meeting.

“1. Each of the following four directors were re-elected to the Company's Board of Directors as Class II directors, to serve until the Company's annual meeting of stockholders in 2029 and until their respective successors are elected and qualified. Each director received the number of votes set forth below. Name For Withheld Broker Non-Votes Robert A. Demichiei 175,709,113 1,710,135 3,488,788 John Driscoll 153,505,736 23,913,512 3,488,788 Paul G. Moskowitz 172,273,095 5,146,153 3,488,788 Lauren Young 176,923,242 496,006 3,488,788”

OUTFRONT Media Inc. shareholders approved Approval of the Amended and Restated Omnibus SIP at the 2026-06-03 meeting.

“(4) Approval of the Amended and Restated Omnibus SIP. Votes For Votes Against Abstentions Broker Non-Votes 151,005,940 4,047,028 51,607 8,678,401”

OUTFRONT Media Inc. shareholders approved Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers at the 2026-06-03 meeting.

“(3) Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. Votes For Votes Against Abstentions Broker Non-Votes 152,430,850 2,593,191 80,534 8,678,401”

OUTFRONT Media Inc. shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP to serve as the Company's independent registered public accounting firm for fiscal year 2026 at the 2026-06-03 meeting.

“(2) Ratification of the appointment of PricewaterhouseCoopers LLP to serve as the Company's independent registered public accounting firm for fiscal year 2026. Votes For Votes Against Abstentions Broker Non-Votes 162,927,914 832,981 22,081 —”

OUTFRONT Media Inc. shareholders approved Election of nine director nominees at the 2026-06-03 meeting.

“(1) Election of nine director nominees. Nominee Votes For Votes Against Abstentions Broker Non-Votes Michael Barrett 154,644,385 433,059 27,131 8,678,401 Nicolas Brien 154,450,564 628,019 25,992 8,678,401 Mark Carleton 154,589,607 487,667 27,301 8,678,401 Angela Courtin 118,265,487 36,810,963 28,125 8,678,401 Manuel A. Diaz 154,302,346 775,868 26,361 8,678,401 Michael J. Dominguez 153,119,550 1,956,556 28,469 8,678,401 Peter Mathes 152,984,679 2,092,860 27,036 8,678,401 Nicolle Pangis 154,917,847 158,643 28,085 8,678,401 Susan M. Tolson 103,030,792 52,045,886 27,897 8,678,401”

GLOBAL INDUSTRIAL Co shareholders approved Approval of the Company's Amended and Restated 2018 Employee Stock Purchase Plan at the 2026-06-01 meeting.

“4. Approval of the Company's Amended and Restated 2018 Employee Stock Purchase Plan. For Against Abstain Broker Non-Votes 35,192,610 21,112 2,820 1,269,589”

GLOBAL INDUSTRIAL Co shareholders approved Advisory (non-binding) vote to approve the compensation of the Company's named executive officers at the 2026-06-01 meeting.

“3. An advisory (non-binding) vote on the compensation of the Company's named executive officers. For Against Abstain Broker Non-Votes 34,706,219 502,371 7,952 1,269,589”

GLOBAL INDUSTRIAL Co shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company's independent auditor for fiscal year 2026 at the 2026-06-01 meeting.

“2. Ratification of the appointment of Ernst & Young LLP as the Company's independent auditor for fiscal year 2026. For Against Abstain Broker Non-Votes 36,323,196 141,794 21,141 0”